| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell, Tumor, and Stem Cell Biology |
Departments of 1 Cell and Molecular Biology and 2 Pathology, Northwestern University Feinberg Medical School, Chicago, Illinois; 3 Department of Obstetrics and Gynecology, New York University, New York, New York; 4 Department of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico, Albuquerque, New Mexico; and 5 Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois
Requests for reprints: M. Sharon Stack, Department of Pathology and Anatomical Sciences, University of Missouri School of Medicine, One Hospital Dr., M263, Columbia, MO 65212. Phone: 573-884-7301; E-mail: Stackm{at}health.missouri.edu.
Reversible modulation of cell-cell adhesion, cell-matrix adhesion, and proteolytic activity plays a critical role in remodeling of the neoplastic ovarian epithelium during metastasis, implicating cadherins, integrins, and proteinases in i.p. metastatic dissemination of epithelial ovarian carcinoma (EOC). Aberrant epithelial differentiation is an early event in ovarian carcinogenesis; thus, in contrast to most carcinomas that lose E-cadherin expression with progression, E-cadherin is abundant in primary EOC. Metastasizing EOCs engage in integrin-mediated adhesion to submesothelial interstitial collagens and express matrix metalloproteinases (MMP) that facilitate collagen invasion, thereby anchoring secondary lesions in the submesothelial matrix. As metalloproteinases have also been implicated in E-cadherin ectodomain shedding, the current study was undertaken to model the effects of matrix-induced integrin clustering on proteinase-catalyzed E-cadherin ectodomain shedding. Aggregation of collagen-binding integrins induced shedding of an 80-kDa E-cadherin ectodomain [soluble E-cadherin (sE-cad)] in a MMP- and Src kinase-dependent manner, and sE-cad was prevalent in ascites from ovarian cancer patients. Expression of MMP-9 was elevated by integrin aggregation, integrin-mediated ectodomain shedding was inhibited by a MMP-9 function blocking antibody, and incubation of cells with exogenous MMP-9 catalyzed E-cadherin ectodomain shedding. In contrast to other tumors wherein sE-cad is released into the circulation, EOC tumors maintain direct contact with sE-cadrich ascites at high concentration, and incubation of EOC cells with physiologically relevant concentrations of recombinant sE-cad disrupted adherens junctions. These data support a novel mechanism for posttranslational modification of E-cadherin function via MMP-9 induction initiated by cell-matrix contact and suggest a mechanism for promotion of EOC metastatic dissemination. [Cancer Res 2007;67(5):20309]
This article has been cited by other articles:
![]() |
N. M. Moss, M. V. Barbolina, Y. Liu, L. Sun, H. G. Munshi, and M. S. Stack Ovarian Cancer Cell Detachment and Multicellular Aggregate Formation Are Regulated by Membrane Type 1 Matrix Metalloproteinase: A Potential Role in I.p. Metastatic Dissemination Cancer Res., September 1, 2009; 69(17): 7121 - 7129. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Zheng, J. G. Lyons, T. K. Tan, Y. Wang, T.-T. Hsu, D. Min, L. Succar, G. K. Rangan, M. Hu, B. R. Henderson, et al. Disruption of E-Cadherin by Matrix Metalloproteinase Directly Mediates Epithelial-Mesenchymal Transition Downstream of Transforming Growth Factor-{beta}1 in Renal Tubular Epithelial Cells Am. J. Pathol., August 1, 2009; 175(2): 580 - 591. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Seifert, H. Ibrahim, T. Stodtmeister, R. Winklbauer, and C. M. Niessen An adhesion-independent, aPKC-dependent function for cadherins in morphogenetic movements J. Cell Sci., July 15, 2009; 122(14): 2514 - 2523. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. A. Kohutek, C. G. diPierro, G. T. Redpath, and I. M. Hussaini ADAM-10-Mediated N-Cadherin Cleavage Is Protein Kinase C-{alpha} Dependent and Promotes Glioblastoma Cell Migration J. Neurosci., April 8, 2009; 29(14): 4605 - 4615. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M. Faca and S. M. Hanash In-Depth Proteomics to Define the Cell Surface and Secretome of Ovarian Cancer Cells and Processes of Protein Shedding Cancer Res., February 1, 2009; 69(3): 728 - 730. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-Q. Wang, H. Li, V. Van Putten, R. A. Winn, L. E. Heasley, and R. A. Nemenoff Oncogenic K-Ras Regulates Proliferation and Cell Junctions in Lung Epithelial Cells through Induction of Cyclooxygenase-2 and Activation of Metalloproteinase-9 Mol. Biol. Cell, February 1, 2009; 20(3): 791 - 800. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Liao, M. K.Y. Siu, C. W.H. Au, E. S.Y. Wong, H. Y. Chan, P. P.C. Ip, H. Y.S. Ngan, and A. N.Y. Cheung Aberrant activation of hedgehog signaling pathway in ovarian cancers: effect on prognosis, cell invasion and differentiation Carcinogenesis, January 1, 2009; 30(1): 131 - 140. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Paredes, A L Correia, A S Ribeiro, F Milanezi, J Cameselle-Teijeiro, and F C Schmitt Breast carcinomas that co-express E- and P-cadherin are associated with p120-catenin cytoplasmic localisation and poor patient survival J. Clin. Pathol., July 1, 2008; 61(7): 856 - 862. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Cowden Dahl, J. Symowicz, Y. Ning, E. Gutierrez, D. A. Fishman, B. P. Adley, M. S. Stack, and L. G. Hudson Matrix Metalloproteinase 9 Is a Mediator of Epidermal Growth Factor-Dependent E-Cadherin Loss in Ovarian Carcinoma Cells Cancer Res., June 15, 2008; 68(12): 4606 - 4613. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sawada, A. K. Mitra, A. R. Radjabi, V. Bhaskar, E. O. Kistner, M. Tretiakova, S. Jagadeeswaran, A. Montag, A. Becker, H. A. Kenny, et al. Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via {alpha}5-Integrin, which Is a Therapeutic Target Cancer Res., April 1, 2008; 68(7): 2329 - 2339. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cao, C. Chiarelli, O. Richman, K. Zarrabi, P. Kozarekar, and S. Zucker Membrane Type 1 Matrix Metalloproteinase Induces Epithelial-to-Mesenchymal Transition in Prostate Cancer J. Biol. Chem., March 7, 2008; 283(10): 6232 - 6240. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Klucky, R. Mueller, I. Vogt, S. Teurich, B. Hartenstein, K. Breuhahn, C. Flechtenmacher, P. Angel, and J. Hess Kallikrein 6 Induces E-Cadherin Shedding and Promotes Cell Proliferation, Migration, and Invasion Cancer Res., September 1, 2007; 67(17): 8198 - 8206. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |